About Duane Hassane, Ph.D.

Dr. Hassane is an Assistant Professor of Computational Biomedicine in Medicine at Weill Cornell Medical College in New York City. He is also an appointed faculty member at the Institute for Computational Biomedicine. He received his postdoctoral training under the mentorship of Dr. Craig T. Jordan at the University of Rochester, one of the world's leading investigators in the development of therapies to target leukemia stem cellsA subpopulation of leukemia cells that resist chemotherapy and are thought to provide a surviving leukemia population that causes relapse.. In Dr. Jordan's laboratory, Dr. Hassane was responsible for development and implementation the genomics program for Dr. Jordan's group, which resulted in the discovery of several new drug candidates for targeting leukemia stem cellsA subpopulation of leukemia cells that resist chemotherapy and are thought to provide a surviving leukemia population that causes relapse..

Currently, Dr. Hassane's independent research program focuses on translational genomicsLeveraging genomic information to deliver near-term clinical results, from technologies such as genome sequencing. in cancer with the ultimate goal of improving the standard of careThe "standard of care" equates to the treatment guidelines for a particular disease. in cancer therapy. Thus, his research focuses on projects that are likely to improve patient care in the near term. To this end, he actively develops collaborative research programs with the excellent Leukemia Program at Weill Cornell/New York Presbyterian Hospital as well as the New York Leukemia Working Group. He also works closely with investigators at the Institute for Computational Biomedicine toward bridging traditional bench biology with advanced technologies including genomic sequencing, bioinformatics, and machine learning algorithmsThe use of artificial intelligence to learn from examples of data, discover hidden and complex patterns in that data, and search for these patterns in new data.. He has been a speaker at several academic and industry forums including the American Society for Hematology, Cambridge Healthtech, and the New York Academy of Sciences.